May 30, 2024
Cell and gene therapies (CGT) represent a growing frontier in medicine, with the potential to transform the treatment of cancer, genetic diseases and more. However, developing these cutting-edge therapies requires highly skilled experience in navigating the complexities of clinical development, manufacturing, analytical testing and commercialization on a global scale.